Clinical Trial Update: Implementing Cabenuva in Arkansas HIV Programs [NA]

View source ↗

Summary

A status update indicates that the Cabenuva trial implementing in Arkansas HIV programs has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CABENUVA (cabotegravir and rilpivirine)

Snippet

Sponsor: University of Arkansas | Conditions: HIV-1-infection, Medication Adherence | NA | Status: TERMINATED